Combined Scintigraphic Study of the Lung: What does the Inhalation Study add?

V. Kempi; C. von Schéele

doi:10.1055/s-0038-1624915

Nuklearmedizin - NuclearMedicine, Table of Contents

Nuklearmedizin 1975; 14(04): 339-345
DOI: 10.1055/s-0038-1624915

Originalarbeiten — Original Articles

Schattauer GmbH

Combined Scintigraphic Study of the Lung: What does the Inhalation Study add?

Die kombinierte szintigraphische Untersuchung der Lungen: Was bringt die Inhalationsuntersuchung zusätzlich?

Authors

V. Kempi

¹Dcpts of Radiophysics and Medicine, Centrallasarettet, Östersund, Sweden
C. von Schéele

¹Dcpts of Radiophysics and Medicine, Centrallasarettet, Östersund, Sweden

Abstract

Summary

In 175 patients the results of combined isotope studies i. e. inhalation and perfusion scintigraphy were compared with those of chest x-ray. The absorbed radiation dose due to the inhalation study calculated for whole body was 3 mrad/500 μCi, lungs 380 mrad/500 μCi, ovaries 0.3 mrad/500 μCi and testes 0.03 mrad/500 μCi.

In 44 of our cases the isotope studies suggested the presence of a vascular occlusion, not detectable on the x-ray film in 36 cases. In the remaining 8 cases the inhalation study was found to add to the precision of the diagnosis. In nearly all other cases it was not found to have any diagnostic value.

An 175 Patienten wurden die Ergebnisse der kombinierten Isotopenuntersuchung der Lungen (Inhalations- und Perfusionsszintigraphie) mit den Röntgenbefunden verglichen. Die berechnete Strahlendosis bei der Inhalationsszintigraphie beträgt für den Ganzkörper 3 mrad/500 μCi, für die Lungen 380 mrad/500 μCi, für die Eierstöcke 0,3 mrad/500 μCi und für die Hoden 0,03 mrad/500 μCi. Die Doppelszintigraphie zeigte bei 44 Patienten vaskuläre Okklusionen; bei 36 von diesen waren die Röntgenuntersuchungen normal. In den übrigen 8 Fällen trug Inhalationszintigraphie zu einer sicheren Diagnose bei. In fast allen anderen Fällen hatte diese Untersuchung keinen diagnostischen Wert.

Full Text

References

References
1 Siegel B. A, Potchen E. J. Radionuclide studies of pulmonary function Progr. Nucl. Med. Baltimore 1973; 49-66.
2 Wagner N. H, Sabiston D. C, Mc Afee J. G, Tow D, Stern H. S. Diagnosis of massive pulmonary embolism in man by radioisotope scanning. N. Engl. J. Med 1964; 271: 377-384.
3 Poulose K. P, Reba R. C, Gilday D. L, Deland F. H, Wagner H. N. Diagnosis of pulmonary embolism. A correlative study of the clinical, scan and angiographic findings. Brit. Med. J 1970; 3: 67-71.
4 Isawa T, Hayes M, Taplin G. V. Radioaerosol inhalation lung scanning: Its role is suspected pulmonary embolism. J. Nucl. Med 1971; 12: 606-609.
5 Moser K. M, Guisan M, Cuomo A, Ashburn W. L. Differentiation of pulmonary vascular from parenchymal diseases by ventilation/perfusion scintiphotography. Ann. Int. Med 1971; 75: 597-605.
6 Bruno F. P, Brookeman V. A, Arborelius M, Williams C. M. ^99mTc -ironhydroxide aggregates for lung scanning. J. Nucl. Med 1970; 11: 134-137.
7 Cook D. J, Lander H. Inhalation lung scanning using carrier-free 113mln. J. Nucl. Med 1971; 11: 765-766.
8 Shoop J. D. Why doalung scan?. J Amer. med. Ass 1974; 229: 567-570.
9 Dillman L. T. Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation. MIRD Pamphlet No. 4. J. Nucl. Med., 1969; 10 (Suppl. 02) Suppl 5-32.
10 Snyder W. S, Ford M. R, Warner G. G, LFisher Jr. H. Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. MIRD Pamphlet No. 5. J. Nucl. Med 1969; 10 (Suppl. 03) Suppl 5-52.
11 Snyder W. S, Ford M. R. Estimates of dose rate to gonads of infants and children from a photon emitter in various organs of the body. Annual Progr. Rpt ORNL-4903. Oak Rigde, Tenn., USA: 1973: 125-129.